Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines
W Ageno, AS Gallus, A Wittkowsky, M Crowther… - Chest, 2012 - Elsevier
Background The objective of this article is to summarize the published literature concerning
the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …
the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …
Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American …
Purpose—The aim of this guideline is to present current and comprehensive
recommendations for the diagnosis and treatment of acute spontaneous intracerebral …
recommendations for the diagnosis and treatment of acute spontaneous intracerebral …
Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American …
Purpose—The aim of this guideline is to present current and comprehensive
recommendations for the diagnosis and treatment of spontaneous intracerebral …
recommendations for the diagnosis and treatment of spontaneous intracerebral …
[PDF][PDF] Guidelines on oral anticoagulation with warfarin
1.1 Žilní trombembolismus Cílová hodnota INR u první epizody žilního trombembolismu má
být 2, 5. V úvodu léčby se má současně s užíváním warfarinu zahájit také parenterální …
být 2, 5. V úvodu léčby se má současně s užíváním warfarinu zahájit také parenterální …
Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council …
Intracerebral hemorrhage (ICH) is more than twice as common as subarachnoid
hemorrhage (SAH) and is much more likely to result in death or major disability than …
hemorrhage (SAH) and is much more likely to result in death or major disability than …
Antidotes for novel oral anticoagulants: current status and future potential
M Crowther, MA Crowther - Arteriosclerosis, thrombosis, and …, 2015 - Am Heart Assoc
The direct thrombin inhibitor dabigatran and the anti-Xa agents rivaroxaban, edoxaban, and
apixaban are a new generation of oral anticoagulants. Their advantage over the vitamin K …
apixaban are a new generation of oral anticoagulants. Their advantage over the vitamin K …
Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy
A Majeed, A Eelde, A Ågren, S Schulman… - Thrombosis research, 2012 - Elsevier
BACKGROUND: There is uncertainty regarding the efficacy and incidence of
thromboembolic events in patients treated with prothrombin complex concentrates (PCC) for …
thromboembolic events in patients treated with prothrombin complex concentrates (PCC) for …
Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient
M Makris, JJ van Veen, R Maclean - Journal of thrombosis and …, 2010 - Springer
The management of patients with supra-therapeutic INR in a common clinical problem. The
risk of bleeding is influenced by the intensity, variability and duration of anticoagulation …
risk of bleeding is influenced by the intensity, variability and duration of anticoagulation …
Current status of pharmacologic therapies in patient blood management
LT Goodnough, A Shander - Anesthesia & Analgesia, 2013 - journals.lww.com
Patient blood management1, 2 incorporates patient-centered, evidence-based medical and
surgical approaches to improve patient outcomes by relying on the patient's own …
surgical approaches to improve patient outcomes by relying on the patient's own …
[HTML][HTML] Reversal of warfarin-induced hemorrhage in the emergency department
M Zareh, A Davis, S Henderson - Western Journal of Emergency …, 2011 - ncbi.nlm.nih.gov
Warfarin, an oral vitamin K antagonist, is used to prevent arterial and venous
thromboembolism in patients suffering from a multitude of diseases. In 2004, 31 million …
thromboembolism in patients suffering from a multitude of diseases. In 2004, 31 million …